Ajente KamalanathanAssociateOgletree, Deakins, Nash, Smoak & Stewart, P.C.Websitewww.ogletree.comOrganization ProfileFull ProfileConnectEmailTwitterLinkedIn202-887-0855 Professional Biography Ajente Kamalanathan is an Associate in the Ogletree Deakins Washington D.C. offices. *Currently licensed in Virginia only. Practice Groups Employment Law Education J.D., American University, 2017 B.A., Virginia Commonwealth University, 2011 Admittance to Practice Virginia More Legal and Business Bylines From Ajente Kamalanathan New Maryland Law Places New Restrictions on Noncompete Agreements for Health Care and Veterinary Professionals - (Posted On Sunday, May 26, 2024) Maryland Prohibits Noncompetes for Low-Wage Employees - (Posted On Wednesday, November 20, 2019) Looking Back to Look Forward: Healthcare Developments in Labor and Employment Law - (Posted On Wednesday, February 06, 2019) Current Legal Analysis Maryland’s Supreme Court Holds That the De Minimis Doctrine Applies to State Wage Laws by: Fiona W. Ong OSHA Enhances Penalty Reductions and Payment Plans for Small Businesses by: John Surma Beltway Buzz, July 18, 2025 by: James J. Plunkett ‘Safe Workplaces, Stronger Partnerships’: Future of OSHA Compliance by: John Surma Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed by: William E. Grob , Zachary V. Zagger Texas Business Organizations Code: Key Amendments Under SB 29 by: Elizabeth Hadley , Christopher M. LaVigne Regulatory Trend: Safeguarding Mental Health in an AI-Enabled World by: Paul D. Squire , Jennifer Bauer Controversial New York Judicial Reorganization Bill Likely to Soon Head to Governor’s Desk by: Joseph T. Burns President Trump Nominates Two for NLRB, Aiming to Restore Quorum by: Gabriel D. Gomez , Sara J. Robertson A Quick Look at Benefits and Executive Compensation Provisions in the One Big Beautiful Bill by: William P. Sweeney , John D. Martini OSH Law Primer, Part XIV: Did OSHA Get It Wrong? Understanding Judicial Review Under the OSH Act by: Ryan J. Swink FDA Authorizes JUUL Labs ENDS Products for U.S. Market by: Azim Chowdhury , LieAnn Van-Tull AI Implications in Senate and House Committees’ Versions of FY 2026 NDAA, and the Pentagon Awards Four AI Contracts Up to $200 Million Each — AI: The Washington Report by: Bruce D. Sokler , Alexander Hecht FDA Extends Comment Period on Method for Ranking Chemicals in Food for Post-Market Assessments by: Lynn L. Bergeson , Carla N. Hutton APHIS Updates Practices for Reviewing Petitions Seeking a Determination of Nonregulated Status for Organisms Altered or Produced through Genetic Engineering by: Lynn L. Bergeson , Carla N. Hutton Upcoming Events Jul 23 2025 The National Association of Women Lawyers 2025 Annual Meeting Jul 21 2025 The Big, Beautiful Webinar Series - Part One: An Introduction to the One Big Beautiful Bill Act Jul 23 2025 Navigating Emerging AI Legislation Jul 23 2025 CEQA Reform Legislation Webinar Print
